Dimers of D76N-β2-microglobulin display potent antiamyloid aggregation activity

Roberto Maya-Martinez1, Yong Xu1, Nicolas Guthertz1

  • 1Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Insights

Transient dimers of D76N-β2m protein inhibit amyloid formation. These specific protein-protein interactions offer new strategies for inhibiting amyloid assembly, crucial for understanding related amyloidosis disorders.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biophysics

Background:

  • Dialysis-related amyloidosis is linked to wild-type beta-2-microglobulin (WT-β2m) self-association into amyloid fibrils.
  • The familial D76N-β2m variant exhibits enhanced aggregation, causing amyloidosis independent of kidney function.
  • Previous studies focused on native protein structures and aggregation potentials, leaving transient oligomers uncharacterized.

Purpose of the Study:

  • To structurally characterize transient dimers of the D76N-β2m protein.
  • To investigate the role of these dimers in the amyloid assembly pathway.
  • To explore the potential of D76N-β2m dimers as inhibitors of amyloid formation.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy
  • Photo-induced crosslinking techniques
  • Structural characterization of transient protein dimers

Main Results:

  • Transient D76N-β2m dimers were detected, trapped, and structurally characterized.
  • These dimers possess distinct structures compared to other β2m dimers.
  • The identified D76N-β2m dimers inhibit amyloid formation by blocking nucleation and elongation.

Conclusions:

  • The structural properties of transient D76N-β2m dimers differ significantly from on-pathway dimers.
  • D76N-β2m dimers act as potent inhibitors of amyloid assembly, even in substoichiometric amounts.
  • Mapping protein-protein interaction interfaces is key to developing novel amyloid inhibition strategies.